Reversal Agents for P‐Glycoprotein‐Mediated Multidrug Resistance

Simon Daenen, Bronno van der Holt, Gregor E.G Verhoef, Bob Löwenberg, Pierre W Wijermans, Peter C Huijgens, Rien van Marwijk Kooy, Harry C Schouten, Mark H.H Kramer, Augustin Ferrant, Eva van den Berg, Monique M.C Steijaert, Leo F Verdonck, Pieter Sonneveld, Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults. Leukemia Research. ,vol. 28, pp. 1057- 1067 ,(2004) , 10.1016/J.LEUKRES.2004.03.001

Akio Shirai, Mikihiko Naito, Tohru Tatsuta, Jian Dong, Kenji Hanaoka, Koji Mikami, Tomoko Oh-hara, Takashi Tsuruo, Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein Biochimica et Biophysica Acta. ,vol. 1222, pp. 400- 404 ,(1994) , 10.1016/0167-4889(94)90047-7

Lajos Pusztai, Peter Wagner, Nuhad Ibrahim, Edgardo Rivera, Richard Theriault, Daniel Booser, Fraser W. Symmans, Franklin Wong, George Blumenschein, Donald R. Fleming, Roman Rouzier, Graeme Boniface, Gabriel N. Hortobagyi, Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma Cancer. ,vol. 104, pp. 682- 691 ,(2005) , 10.1002/CNCR.21227

N Tiffin, K Pritchard-Jones, LR Kelland, HA Cocker, CR Pinkerton, In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line Clinical Cancer Research. ,vol. 7, pp. 3193- 3198 ,(2001)

Alistair J. Stewart, Sade Okiji, Jane A. Plumb, Douglas Bootle, Chris Liddle, Wendy Dangerfield, Prakash Mistry, David Templeton, Peter Charlton, In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Research. ,vol. 61, pp. 749- 758 ,(2001)

G Gerrard, RJ Baker, DT Jones, AB Mehta, M Burgess, K Ganeshaguru, H McCullough, M Ethell, M Potter, E Payne, HG Prentice, Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. Haematologica. ,vol. 89, pp. 782- 790 ,(2004) , 10.3324/%X

T Grand-Perret, F Hyafil, C Vergely, P Du Vignaud, In Vitro and in Vivo Reversal of Multidrug Resistance by GF120918, an Acridonecarboxamide Derivative Cancer Research. ,vol. 53, pp. 4595- 4602 ,(1993)

Gregory D. Leonard, Tito Fojo, Susan E. Bates, The Role of ABC Transporters in Clinical Practice Oncologist. ,vol. 8, pp. 411- 424 ,(2003) , 10.1634/THEONCOLOGIST.8-5-411

A. Seelig, E. Gatlik-Landwojtowicz, Inhibitors of multidrug efflux transporters: their membrane and protein interactions. Mini-reviews in Medicinal Chemistry. ,vol. 5, pp. 135- 151 ,(2005) , 10.2174/1389557053402693

Alan F. List, Kenneth J. Kopecky, Cheryl L. Willman, David R. Head, Diane L. Persons, Marilyn L. Slovak, Robert Dorr, Chatchada Karanes, Harry E. Hynes, James H. Doroshow, Muhammad Shurafa, Frederick R. Appelbaum, Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study. Blood. ,vol. 98, pp. 3212- 3220 ,(2001) , 10.1182/BLOOD.V98.12.3212